Markets

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

1 source ·1 article ·1h ago

For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.

Covered by 1 outlet

Forbes 1

All coverage · 1 article

Forbes Business ·1h ago

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move →

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move